The Pharmacy Times® Mental Health Resource Center is a comprehensive resource for clinical news and expert insights on conditions that affect mood, thinking, and behavior, including clinical depression, bipolar disorder, schizophrenia, anxiety, and post-traumatic stress disorder.
March 21st 2023
New access laws allow pharmacists to establish standing orders with specific physicians or follow blanket, statewide protocols.
Research Finds Impact of Chronic Pain on Daily Life is Biggest Threat to Mental HealthMarch 10th 2023
Persistently pursuing valued goals and adjusting those goals in response to setbacks or obstacles may help explain how some individuals with chronic pain maintain their mental wellbeing.
Study Demonstrates Mechanism of Psychedelic-Induced NeuroplasticityMarch 7th 2023
The study clarifies why serotonin-based therapeutics, such as selective serotonin reuptake inhibitors, do not promote neuroplasticity in the same ways as psychedelics and other psychoplastogenic therapeutics.
There Remain Startling Health Inequities in the Treatment of Substance Use DisorderFebruary 22nd 2023
Substance use disorder is a significant social, economic, and public health crisis, with far too few individuals receiving the treatment they need, particularly among communities of color.
FDA Approves Extended Release Deutetrabenazine for Tardive Dyskinesia, Chorea Associated With Huntington DiseaseFebruary 20th 2023
Austedo XR will be available in 3 extended-release tablet strengths, which provides an updated regimen that may result in a lower pill count for patients.
Prioritizing Patient Pain Before Surgery Can Help Change the Trajectory of the Opioid EpidemicFebruary 9th 2023
Physician outlines the process developed at The Ohio State University Comprehensive Cancer Center to help manage patient pain before, during, and after surgery without the use of opioids.
States With Legal Medical, Recreational Cannabis Policies Do Not Have Significantly Higher Rate of Psychosis-Related OutcomesFebruary 2nd 2023
This is the largest known study to consider medical and recreational cannabis policies with US psychosis-related health care claims.
Study Establishes Connections Between Emotional Maltreatment, Psychiatric DisordersJanuary 27th 2023
In younger children, emotional maltreatment led primarily to behavioral problems, whereas in older children it was more likely to lead to depression and anxiety disorders.
Study: Disclosing Increased Risk of Alzheimer Disease Not Associated With Clinically Meaningful Psychological RiskJanuary 23rd 2023
Researchers noted no significant changes in anxiety or depression between patients who were positive or negative for amyloid deposition.
Sublingual Ketamine Demonstrated to Be Safe, Effective for Patients with Treatment-Resistant DepressionJanuary 18th 2023
Research highlights that 6 doses of sublingual ketamine may be more effective than 3 doses, however both can ameliorate symptoms of anxiety and depression.
Hospitalizations for Mental Health Conditions Increased During the Pandemic Among AdolescentsJanuary 17th 2023
Study notes that evaluating changes in the proportion of hospitalizations for mental health conditions among adolescents is vital to ensure the prioritization of public health programs that address psychiatric health care needs that emerged during the COVID-19 pandemic.
Depression Associated With Lower Medication Adherence Post-Percutaneous Coronary InterventionJanuary 10th 2023
Patients with depression were significantly less likely to have adequate 12-month adherence to antiplatelets, β-blockers, and statins than those without depression.
Physical Activity 3 Times Per Week May Reduce Symptoms of Depression in Children and AdolescentsJanuary 4th 2023
The benefits of physical activity may be greater for children and adolescents with clinical depression or depressive symptoms, who may develop anxiety and other disorders in adulthood.